This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Explore which approach carries less risk for retirement: bonds or index funds. Understand volatility, safety, and long-term impact to guide your plan.
24,864 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
If you want to trim your monthly costs without a dramatic lifestyle change, you’re not alone. This guide shows practi...
The Federal Reserve keeps rates unchanged as Powell's tenure nears its end, citing inflation risks and global tension...
Take-Two’s leader is steering a record $1.5 billion bet on GTA VI, illustrating how blockbuster launches shape person...
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
NVIDIA’s forecast for Q1 2027 signals massive AI infrastructure demand, while Apple charts a different path. The clas...
Grayscale Investments and VanEck filed amendments to their spot BNB ETF registrations with the SEC on May 15, 2026, s...
David Tepper's Appaloosa Management has loaded up on Micron as memory markets rebound, while bets on AMZN and UBER re...
A surge of fear, uncertainty, and doubt sweeps social feeds as Ethereum faces ETF-driven volatility. This report brea...
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
Markets react to policy chatter that a former president invested in Intel and the stock soared. Now investors are wat...